As of 2024-12-11, the Relative Valuation of Angion Biomedica Corp (ANGN) is (28.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.00 USD, the upside of Angion Biomedica Corp based on Relative Valuation is -2925.4%.
The range of the Relative Valuation is (28.61) - (32.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 25.6x | 18.8x |
| Forward P/E multiples | 22.2x - 26.2x | 25.0x |
| Fair Price | (28.61) - (32.99) | (28.25) |
| Upside | -2960.9% - -3399.0% | -2925.4% |
| Date | P/E |